Document is current

Any future updates will be listed below

Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status

Crossref DOI link: https://doi.org/10.1186/s13104-016-1983-9

Published Online: 2016-03-17

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark